- ACRC
Arkansas Cancer Research Center UAMS ACRC Home Search Our Site

Information for Patients
Information for Medical Professionals
Cancer Center Research
Cancer Center Research
About the ACRC

How you can help

Seek Magazine

Martin Hauer-Jensen, MD, PhD
Professor of Surgery and Pathology
Martin Hauer-Jensen, MD, PhD Medical Degree
University of Oslo, Norway

Doctoral Degree
University of Oslo, Norway, Radiation Biology

Postdoctoral Training
University of Iowa, Iowa City, Radiation Biology

Board Certification(s)
American Board of Surgery

Residencies
Deacon Hospital, Oslo, Norway, Surgery
Ullevaal Hospital, University of Oslo, Oslo, Norway, Surgery
University of Oslo, Oslo, Norway, GI Surgery
University of Arkansas for Medical Sciences, Surgery

Clinical Interests
Gastrointestinal surgery
Endoscopy
Surgical oncology

Research Interests
Radiation biology
Gastrointestinal and cardiovascular pathophysiology
Endothelial and vascular biology
Biostatics
Clinical cancer research

E-mail
HauerjensenMartin@uams.edu

Phone
501-686-7912


Visit PubMed for a full listing of this scientist's cancer- related journal articles.

(Disclaimer: This listing may not include all articles associated with this physician or scientist and may include publications related to other physicians or scientists with a similar name.)



Cellular and Molecular Mechanisms of Normal Tissue Radiation Toxicity
Radiation therapy of cancer is intended to have maximum effect on the tumor, while minimizing the exposure of surrounding normal tissues. Despite advances in dose planning and radiation delivery equipment, the risk of injury to normal tissues remains the single-most important factor that limits the likelihood of cancer cure after radiation therapy. Moreover, chronic side effects after radiation therapy are common, associated with significant morbidity and mortality, and are a major determinant of quality of life among cancer survivors. The overall objective of our research program is to investigate the basic mechanisms of normal tissue radiation injury. Such knowledge is important for developing new treatment regimens, effective radiation response modifiers, and adjuvant therapies to minimize normal tissue radiation injury in cancer patients. Current projects are focused on 1) investigating cellular and molecular mechanisms of radiation-induced fibrosis; 2) exploring the mechanisms responsible for the chronic nature of radiation toxicity; and 3) developing strategies to prevent, reduce, or treat normal tissue radiation injury. These studies will provide new insight into the basic pathogenesis of normal tissue radiation toxicity and help reduce the risk of radiation-induced side effects, thereby making radiation therapy safer and more effective.

Information for Patients ~ Information for Medical Professionals
Cancer Institute Research ~ About The Cancer Institute ~ Cancer Institute News and Events
How You Can Help ~ Search Our Site
Cancer Institute Home ~ UAMS Home

Legal Disclaimer
Notice of Privacy Practices

Winthrop P. Rockefeller Cancer Institute
4301 W. Markham St. #623
Little Rock, AR 72205
(501) 686-6000